AMERI Holdings, Inc. (NASDAQ: AMRH), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. today to announce the appointment of George A. Kegler, Jr. to Jay Pharma’s Board of Directors and as Audit Committee Chair, to be effective upon the closing of Jay Pharma’s anticipated merger transaction with Ameri Holdings.
Mr. Kegler is a former executive at Mallinckrodt plc, a leading global specialty pharmaceutical company, where he previously held positions of segment controller, division controller and served as interim chief financial officer. He previously served as chief financial officer of Convatec, a spin-out from Bristol Myers Squibb to private equity groups.
“Mr. Kegler will offer strong financial expertise to Jay Pharma as we build a world-class board of directors with relevant skills and experience,” said Dave Johnson, who plans to join Jay Pharma as Chairman and CEO upon the closing of the Ameri merger transaction. “His decades-long healthcare business knowledge will be an incredible asset to our team, and we believe he will add immense value as future Chair of Jay Pharma’s Audit Committee, while helping to build a foundation to support and propel Jay Pharma’s rapid expansion.”
“I look forward to joining Jay Pharma’s leadership, scientific advisors, and board as we work together to positively impact the lives of persons impacted by cancer,” said Mr. Kegler. “To be a part of an emerging industry is very exciting to me. I admire Jay Pharma’s success in identifying and developing novel approaches to cancer care and I look forward to providing strategic guidance to advance its business.”
Jay Pharma press release: https://jaypharma.co/news/
About Jay Pharma
Jay Pharma is dedicated to developing innovative, evidence-based medicines and combination therapies to address unmet needs in cancer care. Our mission is to improve the lives of persons suffering from cancer, initially by developing over-the-counter products for persons suffering from the side effects of cancer and cancer treatments, and longer term by advancing a pipeline of novel combination therapies as an adjunct to standard of care cancer treatments.
About Ameri100
Ameri is a specialized SAP® cloud, digital, and enterprise solutions company which provides SAP® services to customers worldwide. Headquartered in Suwanee, Georgia, Ameri has offices in the U.S. and Canada. The Company also has global delivery centers in India. With its bespoke engagement model, Ameri delivers transformational value to its clients across industry verticals. For further information, visit www.ameri100.com
